Combining systemic inflammatory response index and albumin fibrinogen ratio to predict early serious complications and prognosis after resectable gastric cancer

Figure 4 Kaplan-Meier analysis of overall survival and disease-free survival based on the systemic inflammatory response index-albumin fibrinogen ratio score of gastric cancer patients in the subgroup. A and B: Patients with tumor-node-metastasis (TNM) I-II; C and D: Patients with TNM III; E and F: Patient received no perioperative transfusion; G and H: Patient received perioperative transfusion; I and J: Patient negative for carcinoembryonic antigen (CEA); K and L: Patient positive for CEA; M and N: Patient without postoperative major complications; O and P: Patient with postoperative major complications. P value was calculated by the log-rank test. SIRI: Systemic inflammatory response index; AFR: Albumin fibrinogen ratio.